Search research publications and outputs

  1. miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of αv- and α6 integrin expression

    Zoni, E., van der Horst, G., van de Merbel, A. F., Chen, L., Rane, J. K., Pelger, R. C. M., Collins, A. T., Visakorpi, T., Snaar-Jagalska, B. E., Maitland, N. J. & van der Pluijm, G., 1 Jun 2015

    Article in Cancer research

  2. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context

    Chapel-Fernandes, S., Jordier, F., Lauro, F., Maitland, N., Chiaroni, J., de Micco, P., Mannoni, P. & Bagnis, C., Oct 2006

    Article in Cancer gene therapy

  3. Use of macrophages to target therapeutic adenovirus to human prostate tumors

    Muthana, M., Giannoudis, A., Scott, S. D., Fang, H-Y., Coffelt, S. B., Morrow, F. J., Murdoch, C., Burton, J., Cross, N., Burke, B., Mistry, R., Hamdy, F., Brown, N. J., Georgopoulos, L., Hoskin, P., Essand, M., Lewis, C. E. & Maitland, N. J., 1 Mar 2011

    Article in Cancer research

  4. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling

    Moroz, O. V., Antson, A. A., Dodson, E. J., Burrell, H. J., Grist, S. J., Lloyd, R. M., Maitland, N. J., Dodson, G. G., Wilson, K. S., Lukanidin, E. & Bronstein, I. B., Mar 2002

    Article in Acta Crystallographica Section D: Biological Crystallography

  5. The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

    Seed, R. I., Taurozzi, A. J., Wilcock, D. J., Nappo, G., Erb, H. H. H., Read, M. L., Gurney, M., Archer, L. K., Ito, S., Rumsby, M. G., Petrie, J. L., Clayton, A., Maitland, N. J. & Collins, A. T., 26 Mar 2019

    Article in Scientific Reports

  6. The dimerization interface of the metastasis-associated protein S100A4 (Mts1) - In vivo and in vitro studies

    Tarabykina, S., Scott, D. J., Herzyk, P., Hill, T. J., Tame, J. R. H., Kriajevska, M., Lafitte, D., Derrick, P. J., Dodson, G. G., Maitland, N. J., Lukanidin, E. M. & Bronstein, I. B., 29 Jun 2001

    Article in Journal of Biological Chemistry

  7. Structure of the intact transactivation domain of the human papillomavirus E2 protein

    Antson, A. A., Burns, J. E., Moroz, O. V., Scott, D. J., Sanders, C. M., Bronstein, I. B., Dodson, G. G., Wilson, K. S. & Maitland, N. J., 17 Feb 2000

    Article in Nature

  8. Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

    Lundqvist, A., Choudhury, A., Nagata, T., Andersson, T., Quinn, G., Fong, T., Maitland, N., Pettersson, S., Paulie, S. & Pisa, P., Sep 2002

    Article in HUMAN GENE THERAPY

  9. Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood

    Georgopoulos, L. J., Elgue, G., Sanchez, J., Dussupt, V., Magotti, P., Lambris, J. D., Tötterman, T. H., Maitland, N. J. & Nilsson, B., Sep 2009

    Article in Molecular immunology

  10. Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes

    Burns, J. E., Walker, H. F., Schmitz, C. & Maitland, N. J., Jun 2010

    Article in VIROLOGY

  11. Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy

    Lipinski, K. S., Djeha, H. A., Gawn, J., Cliffe, S., Maitland, N. J., Palmer, D. H., Mountain, A., Irvine, A. S. & Wrighton, C. J., Jul 2004

    Article in Molecular therapy

  12. Mutations of the BRAF gene in human cancer

    Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, N., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A. & 32 others, Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W. C., Leung, S. Y., Yuen, S. T., Weber, B. L., Siegler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R. & Futreal, P. A., 27 Jun 2002

    Article in Nature

  13. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ

    Thompson, T. C., Southgate, J., Kitchener, G. & Land, H., 24 Mar 1989

    Article in Cell

  14. Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells

    Polson, E. S., Lewis, J. L., Celik, H., Mann, V. M., Stower, M. J., Simms, M. S., Rodrigues, G., Collins, A. T. & Maitland, N. J., 27 Mar 2013

    Article in Nature Communications

  15. Molecular Biology of Wilm's Tumour

    Shaw, A. P. W., Poirier, V., Finerty, S., Berry, P. J., Mott, M. G. & Maitland, N. J., 1988

    Article in Bristol medico-chirurgical journal (1963)

  16. Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin

    Kriajevska, M., Tarabykina, S., Bronstein, I., Maitland, N., Lomonosov, M., Hansen, K., Georgiev, G. & Lukanidin, E., 17 Apr 1998

    Article in Journal of Biological Chemistry

  17. Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

    Santer, F. R., Erb, H. H. H., Oh, S. J., Handle, F., Feiersinger, G. E., Luef, B., Bu, H., Schäfer, G., Ploner, C., Egger, M., Rane, J. K., Maitland, N. J., Klocker, H., Eder, I. E. & Culig, Z., 20 Mar 2015

    Article in Oncotarget

  18. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.

    Polson, ES., Kuchler, VB., Abbosh, C., Ross, EM., Mathew, RK., Beard, HA., da Silva, B., Holding, AN., Ballereau, S., Chuntharpursat-Bon, E., Williams, J., Griffiths, HBS., Shao, H., Patel, A., Davies, AJ., Droop, A., Chumas, P., Short, SC., Lorger, M., Gestwicki, JE. & 6 others, Roberts, LD., Bon, RS., Allison, SJ., Zhu, S., Markowetz, F. & Wurdak, H., 15 Aug 2018

    Article in Science Translational Medicine

  19. JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells

    Kroon, P., Berry, P. A., Stower, M. J., Rodrigues, G., Mann, V. M., Simms, M., Bhasin, D., Chettiar, S., Li, C., Li, P-K., Maitland, N. J. & Collins, A. T., 3 Jul 2013

    Article in Cancer research

  20. Inhibition of T cell activation by normal human biliary epithelial cells

    Cruickshank, S. M., Southgate, J., Selby, P. J. & Trejdosiewicz, L. K., 1 Dec 1999

    Article in Journal of Hepatology

  21. In vitro models to study cellular differentiation and function in human prostate cancers

    Maitland, N. J., Macintosh, C. A., Hall, J., Sharrard, M., Quinn, G. & Lang, S., Jan 2001

    Article in Radiation research

  22. In vitro modelling of the prostate: 3D culture of prostatic cells in matrigel

    Lang, S. H., Stark, M., Hall, J., Hyde, K., Stower, M. & Maitland, N. J., Jul 2001

    Article in British journal of cancer

  23. In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus

    Adamson, R. E., Frazier, A. A., Evans, H., Chambers, K. F., Schenk, E., Essand, M., Birnie, R., Mitry, R. R., Dhawan, A. & Maitland, N. J., 1 Feb 2012

    Article in HUMAN GENE THERAPY

  24. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

    Riddick, A. C. P., Shukla, C. J., Pennington, C. J., Bass, R., Nuttall, R. K., Hogan, A., Sethia, K. K., Ellis, V., Collins, A. T., Maitland, N. J., Ball, R. Y. & Edwards, D. R., 20 Jun 2005

    Article in British journal of cancer

  25. Identification of a putative RNA helicase in E. coli

    Iggo, R., Picksley, S., Southgate, J., McPheat, J. & Lane, D. P., 19 Oct 1990

    Article in Nucleic Acids Research

  26. Human prostate stem cells support replication of a prostate-targeted, conditionally replicating adenovirus

    Frazier, A., Carlisle, R., Evans, H., Georgopoulos, L., Thomson, A., Fisher, K., Seymour, L. & Maitland, N., Nov 2009

    Article in HUMAN GENE THERAPY

  27. Human papillomaviruses and cancer in Uganda

    Newton, R., Bousarghin, L., Ziegler, J., Casabonne, D., Beral, V., Mbidde, E., Carpenter, L., Parkin, D. M., Wabinga, H., Mbulaiteye, S., Jaffe, H., Touzé, A., Coursaget, P., Sembajwe, V., Kalinaki, M., Byansi, R., Rwatooro, C., Nambooze, S., Tushimiere, B., Byabazaire, N. & 10 others, Bitamazire, E., Katabira, E., Mugerwa, J., Tindyebura, D., Ateenyi-Agaba, C., Whitworth, J., Richardson, B., Reeves, G., Weiss, R. & De Cock, K., Apr 2004

    Article in European journal of cancer prevention

  28. Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia

    Bontkes, H. J., de Gruijl, T. D., Bijl, A., Verheijen, R. H. M., Meijer, C. J. L. M., Scheper, R. J., Stern, P. L., Burns, J. E., Maitland, N. J. & Walboomers, J. M. M., Sep 1999

    Article in Journal of general virology

  29. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status (vol 30, pg 1087, 2012)

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Collins, A. T., Maitland, N. J., Risbridger, G. P. & Australian Prostate, Aug 2012

    Article in Stem Cells

  30. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Australian Prostate Cancer Bioresource, N. V., Collins, A. T., Maitland, N. J. & Risbridger, G. P., Jun 2012

    Article in Stem cells (Dayton, Ohio)

Previous 1 2 Next